CVRx Inc

CVRX
9,375
0,895 (10,55%)
Ultimo aggiornamento: 18:26:14
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202422:05GLOBECVRx Reports First Quarter 2024 Financial and Operating..
16/4/202422:30GLOBECVRx to Report First Quarter 2024 Financial and Operating..
15/4/202413:30GLOBECVRx announces availability of additional data supporting..
23/2/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:42EDGAR2Form 144 - Report of proposed sale of securities
14/2/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/2/202422:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/2/202422:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/2/202401:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202414:08EDGAR2Form 8-K - Current report
31/1/202414:00GLOBECVRx Announces Appointment of Kevin Hykes as President and..
25/1/202422:11EDGAR2Form 8-K - Current report
25/1/202422:05GLOBECVRx Reports Fourth Quarter and Full Year 2023 Financial and..
19/1/202415:24EDGAR2Form SC 13D/A - General statement of acquisition of..
11/1/202422:30GLOBECVRx to Report Fourth Quarter 2023 Financial and Operating..
08/1/202414:34EDGAR2Form 8-K - Current report
08/1/202414:30GLOBECVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023..
02/1/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202314:03EDGAR2Form SC 13D/A - General statement of acquisition of..
27/12/202322:30GLOBECVRx to Present at the 42nd Annual J.P. Morgan Healthcare..
26/12/202314:13EDGAR2Form 8-K - Current report
26/12/202314:05GLOBECVRx receives FDA approval for expanded labeling of Barostim
18/12/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:32EDGAR2Form 8-K - Current report
15/11/202322:21GLOBECVRx to Present at the 35th Annual Piper Sandler Healthcare..
03/11/202313:00GLOBECMS Increases Outpatient Payment for Barostim Procedure
31/10/202321:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202322:23EDGAR2Form 8-K - Current report
26/10/202322:15GLOBECVRx Reports Third Quarter 2023 Financial and Operating..
18/10/202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202322:30GLOBECVRx to Report Third Quarter 2023 Financial and Operating..
20/9/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202322:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202300:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202314:30GLOBECVRx to Present at the Canaccord Genuity 43rd Annual Growth..
25/7/202322:20EDGAR2Form 8-K - Current report
25/7/202322:15GLOBECVRx Reports Second Quarter 2023 Financial and Operating..
11/7/202322:30GLOBECVRx to Report Second Quarter 2023 Financial and Operating..
22/6/202322:30GLOBECVRx Set to Join Russell 2000 & 3000 Indexes
25/5/202314:30GLOBECVRx to Present at the William Blair 43rd Annual Growth..
Apertura: 8,72 Min: 8,63 Max: 9,49
Chiusura: 8,48

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network